Jun-zhuo Shi

Kaifeng, 475004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension.

Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial Hypertension.

Journal: Journal of the American Heart Association

Published: May 14, 2026

Subamnex Ameliorates Hypoxia-Induced Pulmonary Arterial Hypertension through Modulation of the STAT3/p-STAT3 Pathway.

Subamnex Ameliorates Hypoxia-Induced Pulmonary Arterial Hypertension through Modulation of the STAT3/p-STAT3 Pathway.

Journal: Journal of medicinal chemistry

Published: April 02, 2026

The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.

The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.

Journal: Journal of hypertension

Published: February 20, 2026

Metabolic reprogramming in pulmonary arterial hypertension.

Metabolic reprogramming in pulmonary arterial hypertension.

Journal: Pharmacology & therapeutics

Published: December 31, 2025

Cftr nominates a novel therapeutic target for Alzheimer's disease: Evidence from integrative omics and in vitro validation.

Cftr nominates a novel therapeutic target for Alzheimer's disease: Evidence from integrative omics and in vitro validation.

Journal: Neuropharmacology

Published: August 04, 2025

Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension.

Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension.

Journal: American journal of hypertension

Published: August 13, 2024

Hypoxanthine Promotes Pulmonary Vascular Remodeling and Adenosine Deaminase Is a Therapeutic Target for Pulmonary Hypertension.

Hypoxanthine Promotes Pulmonary Vascular Remodeling and Adenosine Deaminase Is a Therapeutic Target for Pulmonary Hypertension.

Journal: JACC. Basic to translational science

Published: July 24, 2024

RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.

RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: July 17, 2023

Role of macrophages in pulmonary arterial hypertension.

Role of macrophages in pulmonary arterial hypertension.

Journal: Frontiers in immunology

Published: January 28, 2023

Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-κB pathway in a triple transgenic mouse model.

Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-κB pathway in a triple transgenic mouse model.

Journal: International immunopharmacology

Published: October 11, 2022

Cornuside Is a Potential Agent against Alzheimer's Disease via Orchestration of Reactive Astrocytes.

Cornuside Is a Potential Agent against Alzheimer's Disease via Orchestration of Reactive Astrocytes.

Journal: Nutrients

Published: June 16, 2022

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension.

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension.

Journal: Frontiers in pharmacology

Published: March 31, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026